Activation of the cytokine genes by RelB in GBM cells is the surprising result indicating that RelB acts as a molecular switch converting RelB-dependent silencing into transcriptional activation fueling immunosuppressive inflammation. The gene discussed is RELB; the disease is glioblastoma.